Halozyme Therapeutics Inc. - HALO - stock price prediction, stock price target, analyst ratings from 9 analysts

Halozyme Therapeutics Inc. has a share price target of US$ 71, revenue growth forecast of 30.0%, and profit growth estimate of 53.3% for FY25, based on top 9 analyst calls.